Clinical Genetics Automation – Where are we Now?
SelectScience.net (press release) (registration)
However, the increasing demand for molecular tests by clinicians has put increased demand on routine laboratories to be able to carry out in-house clinical genetics automated testing. Not only that, there is a requirement for increased turn-around …
Myriad Genetics to Present at the 2016 Goldman Sachs Healthcare Conference
GlobeNewswire (press release)
SALT LAKE CITY, June 06, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Mark C. Capone, president and CEO, is scheduled to present at the Goldman Sachs Healthcare Conference at 10:00 a.m. Pacific on June …
Myriad Genetics (MYGN) to Present Positive Data on myRisk Hereditary Cancer Test at ASCO
MYRIAD GENETICS INC. (NASDAQ:MYGN) Financial Condition Compared to S&P 500
Were Analysts Bullish Myriad Genetics, Inc. (NASDAQ:MYGN) This Week?